A multi-institutional research initiative, co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More
Moving Beyond the Binary: How the Convergence of Small and Large Molecules is Reshaping Pharmaceutical R&D
Pharmaceutical R&D is at an inflection point, witnessing a profound transformation that challenges the historical dichotomy between small and large…
Read More
Extra Virgin Olive Oil and the Gut-Brain Axis: New Research Links High-Quality Fats to Cognitive Preservation and Microbial Diversity
The scientific community has long recognized extra virgin olive oil (EVOO) as a foundational element of the Mediterranean diet, attributing…
Read More
The Invisible Conflict Two-Component Dark Matter Model Explains Discrepancy Between Milky Way Gamma-Ray Excess and Dwarf Galaxy Observations
The pursuit of dark matter, the elusive substance believed to constitute approximately 85 percent of the universe’s total matter, has…
Read More
Mezcal worm in a bottle DNA test reveals a surprise
At the bottom of some mezcal bottles sits one of the most recognizable curiosities in the world of spirits: a…
Read More
Stanford Medicine Researchers Identify Glucose as a Master Regulator of Tissue Differentiation Beyond Its Role as an Energy Source
In a paradigm-shifting discovery that challenges over a century of biochemical dogma, researchers at Stanford Medicine have revealed that glucose—the…
Read More
Lilly Emerges as Top Pharma Company by Revenue in FY2025, Fueled by Mounjaro and Zepbound’s $36.5 Billion Success
Eli Lilly and Company has officially concluded its fiscal year 2025 as the world’s leading pharmaceutical enterprise by revenue, a…
Read More
Breakthrough in Piezoelectric Chip Design Promises to Revolutionize Data Center Energy Efficiency and GPU Power Delivery
As the global appetite for artificial intelligence and cloud computing continues to accelerate, the infrastructure supporting these technologies is facing…
Read More
Apotex Acquires Cumberland Pharmaceuticals’ Branded Drug Portfolio for $100 Million, Ushering in New Era for Both Companies
Canadian pharmaceutical giant Apotex has announced a significant strategic acquisition, agreeing to purchase Cumberland Pharmaceuticals’ entire portfolio of branded commercial…
Read More
A Sweeping Genetic Analysis Challenges Single-Origin Theory, Revealing a Complex Tapestry of Human Ancestry in Africa
A groundbreaking genetic analysis, published in the prestigious journal Nature in 2023, is compelling scientists to re-evaluate fundamental assumptions about…
Read More
